Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. Mai 2025 08:00 ET | Quelle: RENEXXION IRELAND

Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Completion of Enrollment of the Global Phase 2b Study Evaluating Naronapride in Gastroparesis (MOVE-IT)

ROSCREA, Ireland and FREIBURG, Germany, May 27, 2025 (GLOBE NEWSWIRE) -- Renexxion Ireland Limited (“Renexxion”), a private biopharmaceutical company committed to delivering innovative drugs to...
26. November 2024 08:00 ET | Quelle: RENEXXION IRELAND

Renexxion Ireland Ltd. Announces Issuance of Fifth New U.S. Patent Covering Novel Crystal Isoform of Naronapride

Renexxion Ireland Ltd marks a major milestone in its intellectual property portfolio.
10. Mai 2023 09:00 ET | Quelle: G-Tech Medical

Results of Pilot Study That Monitored Patients with Functional Dyspepsia, Gastroparesis and Vomiting Presented at Digestive Disease Week 2023

MOUNTAIN VIEW, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- G-Tech Medical today announced an oral presentation of an abstract entitled A Novel, Non-invasive, 6-day Wireless Motility Patch System...
09. Mai 2023 09:00 ET | Quelle: G-Tech Medical

Interim Results of Study That Used Non-invasive Wireless Patches to Monitor Myoelectric Activity of Crohn’s Disease Patients in Flare and Remission

MOUNTAIN VIEW, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced presentation of...
13. Januar 2022 09:00 ET | Quelle: G-Tech Medical

G-Tech Medical Receives FDA Clearance for its Gastrointestinal Motility Monitoring System

MOUNTAIN VIEW, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced U.S. Food and...